戻る
Vor Biopharma Inc (VOR)価格
VOR 株価推移チャート
VOR 収入
Vor Biopharma Inc
$13.16
9.03%
$1.08
終値： Feb 06, 16:00:00 GMT-5
$13.12
-0.25%
$-0.03
アフターマーケット：Feb 06, 20:00:00 GMT-5
主要データ
前終値
$12.07
始値
$12.31
当日レンジ
$12.27 - $13.78
52週レンジ
$2.62 - $65.8
取引高
1.0M
平均取引高
1.9M
1株当たり利益(TTM)
-386.85
配当利回り
--
時価総額
$287.5M
VORとは何ですか？
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. The company is headquartered in Boston, Massachusetts and currently employs 159 full-time employees. The company went IPO on 2021-02-05. The firm is focused on rapidly advancing telitacicept, a dual-target fusion protein, through Phase III clinical development and commercialization to address serious autoantibody-driven conditions worldwide. Telitacicept is an investigational recombinant fusion protein designed to treat autoimmune diseases by selectively inhibiting BLyS (BAFF) and APRIL - two cytokines essential to B cell and plasma cell survival. This dual-target mechanism reduces autoreactive B cells and autoantibody production, key drivers of autoimmune pathology. Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase III clinical trial in gMG is underway across the United States, Europe, and South America to support potential approval in the United States and Europe.